scholarly article | Q13442814 |
P2093 | author name string | Michael N Gould | |
Jenny E Gumperz | |||
Nicholas A Zumwalde | |||
Deepak Sharma | |||
Lee G Wilke | |||
Jill D Haag | |||
Jennifer A Mirrielees | |||
P2860 | cites work | Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells | Q27680609 |
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells | Q27682926 | ||
Regulation of cutaneous malignancy by gammadelta T cells | Q28188439 | ||
Immunosurveillance and immunoregulation by gammadelta T cells | Q28292156 | ||
Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells | Q28660812 | ||
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials | Q30982699 | ||
V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer | Q71668739 | ||
Reconstruction of human mammary tissues in a mouse model | Q80092812 | ||
Characterization of the gammadelta T cell response to acute leukemia | Q81575021 | ||
Check MAIT. | Q33630962 | ||
Quantification of epithelial cell differentiation in mammary glands and carcinomas from DMBA- and MNU-exposed rats | Q34056061 | ||
Endocrine therapy plus zoledronic acid in premenopausal breast cancer. | Q34943802 | ||
Anatomical localization of progenitor cells in human breast tissue reveals enrichment of uncommitted cells within immature lobules | Q35000334 | ||
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid | Q35431110 | ||
The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions | Q35608722 | ||
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis | Q35763387 | ||
Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations | Q35770336 | ||
Defining the cellular precursors to human breast cancer | Q35778960 | ||
Leukocyte composition of human breast cancer | Q35779386 | ||
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium | Q35797147 | ||
Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism | Q35889808 | ||
Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells | Q36370502 | ||
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients | Q36399628 | ||
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity | Q36490747 | ||
Processing of human reduction mammoplasty and mastectomy tissues for cell culture | Q36639586 | ||
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck | Q36648706 | ||
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens | Q36732656 | ||
Curriculum vitae of intestinal intraepithelial T cells: their developmental and behavioral characteristics | Q36732684 | ||
Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer | Q36800215 | ||
Exploring the anti-tumour activity of bisphosphonates in early breast cancer. | Q37142755 | ||
The utility of comparative genetics to inform breast cancer prevention strategies | Q37397442 | ||
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis | Q37426789 | ||
Immune cell quantitation in normal breast tissue lobules with and without lobulitis. | Q37656390 | ||
Bisphosphonates and breast cancer incidence and recurrence | Q37964829 | ||
Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells | Q39313746 | ||
High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. | Q39529604 | ||
Activation of γδ T cells by bisphosphonates. | Q39924204 | ||
Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer | Q39990395 | ||
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. | Q40106388 | ||
Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells | Q41029784 | ||
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin | Q41429601 | ||
IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment | Q41549864 | ||
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. | Q43073125 | ||
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. | Q43162657 | ||
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. | Q44575984 | ||
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts | Q47954287 | ||
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis | Q60241749 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | organoid | Q11293125 |
breast carcinoma | Q18555947 | ||
P304 | page(s) | 305-316 | |
P577 | publication date | 2016-01-25 | |
P1433 | published in | Cancer Prevention Research | Q2665103 |
P1476 | title | Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate | |
P478 | volume | 9 |
Q40146526 | Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model |
Q90616712 | An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer |
Q40207403 | Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells. |
Q37304964 | Leveraging premalignant biology for immune-based cancer prevention |
Q49838268 | Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand |
Q58748503 | Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells |
Q58737628 | Organoid technology and applications in cancer research |
Q52564853 | Organoids in cancer research. |
Q92097336 | Organoids in immunological research |
Q38857539 | Precancer Atlas to Drive Precision Prevention Trials. |
Q92723894 | Preclinical Modelling of PDA: Is Organoid the New Black? |
Q59806979 | Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells |
Q91698737 | Xenograft and organoid model systems in cancer research |
Search more.